Small Cell Lung Carcinoma: all 1,234 studies

Page 12 of 13. Open to participants first (350), then studies with results posted, then the rest; newest registration first within each.

• Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer PatientsCompletedNCT00466466Phase 1
• Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung CancerCompletedNCT00466232Phase 1
• Study of Picoplatin Efficacy After RelapseStatus unknownNCT00465491Phase 3
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
• A Study of Intravenous XMT-1001 in Patients With Advanced Solid TumorsCompletedNCT00455052Phase 1
• Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung CancerCompletedNCT00453167Phase 2
• Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)CompletedNCT00452634Phase 2
• A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological MalignanciesCompletedNCT00445198Phase 1/2
• Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung CarcinomaTerminatedNCT00435578Phase 2
• Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung CancerCompletedNCT00433563Not applicable
• Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung CancerCompletedNCT00433498Phase 3
• Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
• Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)Status unknownNCT00418743
• G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly PatientsCompletedNCT00401609Phase 1/2
• Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung CancerCompletedNCT00397293Phase 1/2
• Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung CancerCompletedNCT00388960Phase 2
• Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00387699Phase 2
• Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior TherapyCompletedNCT00375193Phase 2
• A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung CancerCompletedNCT00359359Phase 1/2
• A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung CancerCompletedNCT00349492Phase 3
• Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)TerminatedNCT00324558Phase 2
• Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung CancerCompletedNCT00320359Phase 3
• Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.CompletedNCT00319969Phase 2
• A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung CancerCompletedNCT00317200Phase 2
• Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung CancerTerminatedNCT00316433Phase 2
• Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung CancerTerminatedNCT00315211Phase 2
• Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCompletedNCT00308529Phase 2
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung CancerTerminatedNCT00299390Phase 2
• A Study of IRESSA in Relapsed and Refractory Small Cell Lung CancerCompletedNCT00298688Phase 2
• Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00294931Phase 2
• Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung CancerCompletedNCT00294190Phase 2
• Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + EtoposideCompletedNCT00290953Phase 2/3
• Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)TerminatedNCT00286169Phase 3
• VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung CancerCompletedNCT00282022Phase 2
• Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung CancerCompletedNCT00276276Phase 3
• The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyCompletedNCT00270166Phase 3
• Metabolomic Analysis of Lung CancerCompletedNCT00263731
• A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid TumorsCompletedNCT00259935Phase 1
• Doxil Topotecan Doublet Cancer StudyCompletedNCT00252889Phase 1
• Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00248482Phase 2
• Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00227565Phase 2
• Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung CancerTerminatedNCT00216216Phase 2
• Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer PatientsCompletedNCT00213798Not applicable
• Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung CancerCompletedNCT00193401Phase 2
• Weekly Topotecan in the Second-Line Treatment of Small Cell Lung CancerCompletedNCT00193388Phase 2
• A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedCompletedNCT00191750Phase 2
• Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsStatus unknownNCT00178698Phase 2
• Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)Status unknownNCT00168922Phase 2
• A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease StageStatus unknownNCT00168896Phase 2/3
• Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLCCompletedNCT00156286Phase 2
• A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLCCompletedNCT00144989Phase 3
• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704
• Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung CancerCompletedNCT00132054Phase 1
• Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung CancerCompletedNCT00126828Phase 1/2
• A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin AlfaCompletedNCT00119613Phase 3
• Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung CancerCompletedNCT00118235Phase 2
• Picoplatin as Second-Line Therapy for Patients With Small Cell Lung CancerCompletedNCT00116610Phase 2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
• Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerCompletedNCT00104793Phase 2
• Liposomal SN-38 in Treating Patients With Small Cell Lung CancerWithdrawnNCT00104754Phase 2
• Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal CancerTerminatedNCT00088933Phase 1
• Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung CancerTerminatedNCT00087048Phase 2
• Romidepsin in Treating Patients With Relapsed Small Cell Lung CancerCompletedNCT00086827Phase 2
• Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00083161Phase 2
• Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)CompletedNCT00080015Phase 2
• Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00072527Phase 2
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
• Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyCompletedNCT00068289Phase 2
• ZD6474 in Treating Patients With Small Cell Lung CancerCompletedNCT00066313Phase 2
• Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00062322Phase 1
• Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung CancerCompletedNCT00061919Phase 3
• Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00059761Phase 1
• Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00053300Phase 2
• Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00052949Phase 2
• Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00052494Phase 1
• Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00049218Phase 1/2
• Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung CancerCompletedNCT00046787Phase 2
• A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid TumorsCompletedNCT00046111Phase 1
• S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung CancerTerminatedNCT00045617Phase 2
• Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00045604Phase 1
• Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive AdultsCompletedNCT00043927Phase 3
• The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)CompletedNCT00043862Phase 2
• Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00042978Phase 2
• Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00041054Phase 2
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00041015Phase 3
• Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesCompletedNCT00037817Phase 1
• Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCGCompletedNCT00037713Phase 3
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00033696Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00028925Phase 2
• Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsCompletedNCT00028535Phase 1
• CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00028028Phase 2
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00025272Phase 2
• Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung CancerCompletedNCT00022711Phase 2
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung CancerCompletedNCT00021333Phase 2
• FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung CancerCompletedNCT00020202Phase 2
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerCompletedNCT00019006Phase 1
• Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung CancerCompletedNCT00016211Phase 3
• BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous TreatmentStatus unknownNCT00014547Phase 2
• Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung CancerStatus unknownNCT00011921Phase 3

← Small Cell Lung Carcinoma overview